| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,003 | 0,009 | 17:33 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| WESANA HEALTH Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,950 | -2,70 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| ESSILORLUXOTTICA | 141,40 | -2,78 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| SERNOVA BIOTHERAPEUTICS | 0,068 | +5,56 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 133,10 | +1,45 % | Should You Continue to Hold ALGN Stock in Your Portfolio? | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| HEALWELL AI | 0,465 | +1,53 % | HEALWELL AI: HEALWELL's DARWEN AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research | New research accepted for presentation at AMIA 2026 demonstrates the performance of HEALWELL's DARWEN AI-powered SMARTSuite, including clinical summarization results that outperformed published benchmarks... ► Artikel lesen | |
| INMODE | 12,640 | -0,59 % | InMode slips as unsolicited takeover offer from M.N. Business Strategy expires | ||
| ATOSSA THERAPEUTICS | 2,140 | +1,90 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| SPINEWAY | 0,120 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| ELEVANCE HEALTH | 361,80 | +0,58 % | Dividendenbekanntmachungen (10.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADT INC US00090Q1031 0,055 USD 0,0472 EUR ALAMOS GOLD INC CA0115321089 0,04 USD 0,0343 EUR ALPINE INCOME PROPERTY TRUST INC US02083X1037 0... ► Artikel lesen | |
| MORE LIFE COMPANY | 0,032 | -13,71 % | XFRA NEW INSTRUMENTS AVAILABLE ON 24.08.2026 | The following instruments on XETRA do have their first trading 24.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.08.2026
Aktien
1 CA0966311064 Boardwalk Real Estate... ► Artikel lesen | |
| VERU | 2,390 | +3,02 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,940 | -0,76 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| BONESUPPORT | 19,770 | +2,17 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen |